CClinicalTrials.gg
CompletedNCT06540924Updated Aug 9, 2024

Investigation of LBX1, TIMP2, GPR126 and CHD7 Gene Polymorphisms in Adolescent Idiopathic Scoliosis Patients

An observational study in Adolescent Idiopathic Scoliosis and Single Nucleotide Polymorphisms, sponsored by Uludag University. Completed at 1 site in Turkey. Open to participants aged 10 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-09.

Sponsored by Uludag University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
301
Ages
10 Years to 18 Years
Sex
All
01

Study summary

Adolescent Idiopathic Scoliosis (AIS) is a common disease of the spine observed in individuals aged 10-18 who typically do not have any other health issues. Despite numerous genetic studies conducted across different ethnic groups worldwide, the specific genes contributing to the development of scoliosis have not yet been definitively identified. Therefore, the aim of our study is to investigate whether there is an etiological relationship between AIS and the polymorphisms of the LBX1 (rs11190870, rs625039, rs11598564), TIMP2 (rs8179090), GPR126 (rs6570507), and CHD7 (rs121434341) genes in the Turkish population and to determine the relationship of these polymorphisms with gender, age, age at diagnosis and Cobb angle in these patients.

Read the detailed description

This prospective genetic research was conducted Bursa Uludag University Faculty of Medicine, Department of Orthopedics and Traumatology. A total of 301 individuals were included in the study, comprising 201 patients aged 10-18 years diagnosed with AIS and Cobb angle of 10 degrees or more on direct radiography, no known genetic disorders and no diseases known to play a role in the etiology of scoliosis and 100 healthy controls aged 10-18 years without a diagnosis of scoliosis based on physical examination and/or imaging. In the study, the LBX1, TIMP2, GPR126 and CHD7 gene polymorphisms in AIS patients and the control group were analyzed using real-time PCR with TaqMan probe SNP (single nucleotide polymorphism) primers (rs625039, rs11598564, rs6570507, rs121434341, rs11190870, rs8179090). Subsequently, the SNP regions were confirmed by DNA sequence analysis. The obtained findings were statistically analyzed.

02

Conditions studied

  • Adolescent Idiopathic Scoliosis
  • Single Nucleotide Polymorphisms

Browse trials for

Keywords

  • Adolescent idiopathic scoliosis
  • genetic
  • single nucleotide polymorphism
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 301 is above the median of 89 across 233 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Uludag University is the lead sponsor of 141 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals applying to Uludag University Orthopedics and Traumatology polyclinic.

Inclusion criteria

Study group

  • Being diagnosed with Adolescent Idiopathic Scoliosis (AIS) between the ages of 10 and 18.
  • Having a Cobb angle of 10 degrees or greater on a plain radiograph.
  • Not having any known genetic disorders.
  • Not having any diseases known to play a role in the etiology of scoliosis (degenerative, neuromuscular, congenital scoliosis, etc., are excluded).

Control group

  • Healthy individuals who have not been diagnosed with scoliosis by physical examination and/or imaging.
  • Being between the ages of 10-18

Exclusion criteria

Exclusion Criteria:

Study group

  • Those diagnosed with non-idiopathic scoliosis.
  • Individuals who develop scoliosis after the age of 18.
  • Individuals with scoliosis under the age of 10.
  • Those diagnosed with a genetic disease.
  • Those diagnosed with any disease known to play a role in the etiology of scoliosis.

Control group

  • Those who have physical examination suspicion of scoliosis.
  • Those with a Cobb angle of 10 degrees or more on plain radiographs.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
301 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Study group

    Being diagnosed with Adolescent Idiopathic Scoliosis (AIS) between the ages of 10 and 18 group. Having a Cobb angle of 10 degrees or greater on a plain radiograph. Not having any known genetic disorders. Not having any diseases known to play a role in the etiology of scoliosis (degenerative, neuromuscular, congenital scoliosis, etc., are excluded).

    Other: single nucleotide polymorphisms

  • Control group

    Healthy individuals between the ages of 10-18 who do not have scoliosis by physical examination and/or imaging.

    Other: single nucleotide polymorphisms

Interventions

  • Othersingle nucleotide polymorphisms

    The LBX1 (Ladybird Homeobox 1), TIMP2 (Tissue Inhibitor of Metalloprotease 2), GPR126 (G Protein-Coupled Receptor 126) and CHD7 (Chromodomain Helicase DNA Binding Protein 7) gene polymorphisms in adolescent idiopathic scoliosis patients and the control group were analyzed using real-time PCR with TaqMan probe SNP (single nucleotide polymorphism) primers (rs625039, rs11598564, rs6570507, rs121434341, rs11190870, rs8179090).

06

What researchers measure

Primary outcomes

  1. Investigation of LBX1, TIMP2, GPR126, and CHD7 Gene Polymorphisms in 201 Turkish Adolescents With Idiopathic Scoliosis

    Despite numerous genetic studies conducted across different ethnic groups worldwide, the specific genes contributing to the development of scoliosis have not yet been definitively identified. Therefore, the aim of investigator is to investigate whether there is an etiological relationship between adolescent idiopathic scoliosis and the polymorphisms of the LBX1 (rs11190870, rs625039, rs11598564), TIMP2 (rs8179090), GPR126 (rs6570507), and CHD7 (rs121434341) genes in the Turkish population.

    Time frame: 12 months

07

Study locations

1 site
  • Uludag University
    Bursa, 16059, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06540924
Lead sponsor
Uludag University
Responsible party
Erkan Bilgin (Specialist medical doctor, Uludag University) — Principal investigator
First posted
Aug 6, 2024
Start date
Jul 8, 2022
Primary completion
Dec 8, 2022
Completion
Jul 8, 2023
Last update
Aug 9, 2024

Study contacts

Erkan Bilgin, Doctor
principal investigator · Uludag University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion